The study by Lin et al. supports that the hepatocellular protective effects of chemerin are immune-mediated involving a shift from tumor-infiltrating immunosuppressive and angiogenesis-stimulating MSDCs to tumor-suppressing interferon γ-secreting T cells (IFNγ+T) (Figure 4). The gene discussed is IFNG; the disease is neoplasm.